• About PRIME
  • Advertise With Us
  • Contact Us
Advertisement
PRIME Journal
  • Home
  • Digital Issue
  • Categories
    • Energy Based Devices
    • Minimally Invasive
    • Skincare
    • Injectables
    • Dermatology
    • Anti-ageing
    • Body Contouring
    • Invasive treatments
  • Features
    • Case Study
    • PRIME People
    • Company Profile
    • Industry Analysis
    • Sponsored Features
  • News
  • Sign Up
  • Login

Select Page

PRIME September/October 2024 issue

Digital Magazine, News

Share:

PreviousPRIME July/August 2024 issue
NextAMWC CHINA: Celebrating Innovation in Aesthetic Medicine

Related Posts

Scientists May Have Discovered A ‘Holy Grail’ For Healing Scars

Scientists May Have Discovered A ‘Holy Grail’ For Healing Scars

June 2, 2021

Study finds non-invasive lifts of eyebrow, neck and chin are effective

Study finds non-invasive lifts of eyebrow, neck and chin are effective

January 16, 2015

U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite

U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite

July 7, 2020

Almirall enters into a definitive agreement to divest ThermiGen, its medical device aesthetics business

Almirall enters into a definitive agreement to divest ThermiGen, its medical device aesthetics business

March 8, 2019

Search

Login Status

Forgot?  Register

January/February 2026 Issue

Advertisement

Upcoming Events

No events are found.

All events

Categories

  • Injectables
  • Dermatology
  • Anti-ageing
  • Body Contouring
  • Invasive treatments
  • Case Study
  • Practice Management
  • Sponsored
  • Industry Insider
  • Company Profile
  • PRIME People
  • Meeting reviews
  • Commentary

Designed by Elegant Themes | Powered by WordPress

  • Contact Us
  • Editorial Board
  • Terms & Conditions
  • Privacy Policy